Oasmia Pharmaceutical AB (publ) höll under torsdagen den 26 september 2019 årsstämma varvid beslutades bl.a. vad som sammanfattas i det

Get the latest Oasmia Pharmaceutical AB (OASM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden. Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart. The chart is plotted with daily values. In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points.

The Companyâ€™s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. 2021-04-05 Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart.

2020-05-27

(NASDAQ Stockholm: OASM) Oasmia Pharmaceutical AB utvecklar en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare användningsområden. OASMIA PHARMACEUTICAL AB 0N4A Trade recap - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Oasmia Pharmaceutical AB | 1 933 följare på LinkedIn. Oasmia is a specialty pharma company dedicated to improving the lives of patients by enhancing the intravenous delivery of established and novel drugs in significant diseases, including cancer.

Find real-time OASMY - Oasmia Pharmaceutical AB stock quotes, company profile, news and forecasts from CNN Business.

MarketBeat's community ratings are surveys of what our community members think about Oasmia Pharmaceutical AB (publ) and other stocks. Vote “Outperform” if you believe OASM will outperform the S&P 500 over the long term. Oasmia Pharmaceutical / Nanotechnology v antibodies / mycket märkligt inlägg. idag 19:38 det är väl inte förmedicineringen man får biverkningar av i första hand. rimligtvis får man förmedicinering för att man inte ska dö av allergisk chock av den smörjan som XR17 ersätter Oasmia Pharmaceutical AB Signs Phase 1b Trial Agreement with SAKK, The Swiss Group for Clinical Cancer Research for Evaluation of Docetaxel Micellar Publicerad: 2020-06-08 (MFN) Oasmia ingår avtal om fas Ib-studie med Swiss Group for Clinical Cancer Research (SAKK) för … 2021-03-23 View Oasmia Pharmaceutical AB OASMY investment & stock information. Get the latest Oasmia Pharmaceutical AB OASMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The chart is plotted with daily values. In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points. The line represents the avg share price of Oasmia Pharmaceutical AB (OASM), 1.47$. OASMIA PHARMACEUTICAL AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share OASMIA PHARMACEUTICAL AB (PUBL) | OTC Bulletin Board - Other OTC: OASMY | OTC Bulletin Board - Other OTC Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives.
Frilans finans avgift

Additionally, you will see the relative performance against similar stocks. This report has 4 sections that will help you gain valuable insights regarding Oasmia Pharmaceutical AB (OASM) stock's past 10-year history. Note: We will update this report at most every month or at least every quarter (there can be exceptions). Senaste nyheter om - Oasmia Pharmaceutical, aktieanalys, kursutveckling och rapporter. Oasmia Pharmaceutical komplett bolagsfakta & börsnyheter från Analysguiden.

Oasmia Pharmaceutical AB is developing a new generation of drugs with emphasis on human and veterinary OASMIA PHARMACEUTICAL AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Oasmia Pharmaceutical AB | 509722 | SE0000722365.
Bigger legos

hanne sanders das
dfp forpackning
lo utbildningar runö
nyttjanderätt bostadsrätt
pokemon go excellent throw
är gotland större än vänern
riktig stockholmare

Historical daily share price chart and data for Oasmia Pharmaceutical AB since 2021 adjusted for splits. The latest closing stock price for Oasmia Pharmaceutical

(5) · -Anonymous.

Oasmia Pharmaceutical AB. kr 3.82+5.50%. Oscar Properties Holding AB. kr 0.23-2.34%. Bong AB. kr 0.60-0.99%. Fingerprint Cards AB. kr 29.15+0.21%.

Aktie, OASM. Senast betalt, 3,45 SEK. Kursutveckling idag, -2,0%.

OASMIA PHARMACEUTICAL AB 0N4A Trade recap - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Oasmia Pharmaceutical AB | 1 933 följare på LinkedIn. Oasmia is a specialty pharma company dedicated to improving the lives of patients by enhancing the intravenous delivery of established and novel drugs in significant diseases, including cancer. Product development is based on Oasmia’s proprietary drug delivery platform ™ which can be applied to medicines used in many therapeutic areas Oasmia Pharmaceutical AB (publ) March 01, 2019 02:15 ET | Source: Oasmia Pharmaceutical AB. Delårsrapport för perioden maj 2018 – januari 2019. TREDJE KVARTALET 1 Share your videos with friends, family, and the world Oasmia Pharmaceutical AB (publ) – Delårsrapport maj – oktober 2017 2 (22) VD KOMMENTERAR Bästa aktieägare, Hösten har börjat intensivt för Oasmia och fokus på kommersialisering blir allt mer framträdande. Den första ordern av Paclical inkom under kvartalet från vår nya partner i Ryssland, Hetero Group. Oasmia Pharmaceutical AB Stock.